search innovation
New uv-blocker for sunscreen with high bactericidal activity
keywords: cosmetics, sunscreen, skin care, medical applications
offer number: 250

The offered material is based on ZnO nanoparticles, modified with biocompatible polymer – chitosan. The material is characterized with high absorption properties of the sun's ultraviolet (UV) radiation. Also, high antibacterial activity against resistant bacterial strains and the absence of cytotoxic activity against human skin cells of the material were confirmed.



Sun protection
Sunblock typically refers to opaque sunscreen that is effective at blocking both UVA and UVB rays and uses a heavy carrier oil to resist being washed off. Titanium dioxide and zinc oxide are two of the important ingredients in sunblock. Unlike the organic sun-blocking agents used in many sunscreens, these metal oxides do not degrade with exposure to sunlight. However, photoreactivity of commercially available suntan lotions and their components (mainly TiO2) leads to formation of Reactive Oxygen Species (ROS), which are responsible for example for DNA damaging and skin ageing.

Multifunctional ZnO – biopolymer
Presented nanocomposites are based on nanoparticles of zinc oxide (ZnO). The surface of nanoparticles is additionally modified with biocompatible polymer - chitosan (CS).

The main advantages of the invention are:
  • excellent absorption of UVA/UVB,
  • low refractive index,
  • chemical stability,
  • antibacterial activity against resistant bacterial strains (Staphylococcus aureus, Escherichia coli),
  • lack of cytotoxic effect against human keratinocytes.

Multifunctional ZnO – biopolymer composite resolves the risks associated with the use of semiconductor nanoparticles as active ingredients in sunscreen.

The material is the subject of patent application and the invention is still developed by the scientists from Faculty of Chemistry, Jagiellonian University.

Currently the Centre for Technology Transfer CITTRU is looking for the entities interested in the commercial applications of the described solution. CITTRU is looking for the business partners for joint research and development projects involving the above research topic.
commercial utility: cosmetics, sunscreen, skin care, medical applications
field of science: chemistry, chemical engineering, medicine
forms of protection: patent application
technological maturity: demanding R & D
property rights: Jagiellonian University
variants of cooperation: license, consulting, spin-off company, comercial contract research, sale

information / broker of Jagiellonian University

name and surname: Paula Janus, PhD
phone number: + 48 12 664 42 16, +48 506 006 590
NEWS
latest information
ATOMIN 2.0 - ATOMic scale science for the INnovative economy

A center for atomic-scale materials research for an innovative economy, the so-called Atomin 2.0 project, has been established as a part of a joint venture of the Faculty of Chemistry and the Faculty of Physics, Astronomy and Applied Computer Science, Jagiellonian University.

Big Pharma Day online
Big Pharma Day online is an industry meeting on the development of drug projects, organized by CTT CITTRU, happening on March 25, 2021. The event will include expert presentations and individual meetings.
A new, effective method for obtaining common ash cuttings
Discover a new technology for obtaining cuttings of common ash developed by the interdisciplinary research team from the Jagiellonian University and the University of Agriculture in Krakow.
CITTRU team
Our employees
PARTNERS
Innovation Forum KrakówKlaster Lifescience KrakówWolves SummitPACTTJagiellońskie Centrum Innowacji
Contact
GET IN TOUCH WITH US
Centre for Technology Transfer CITTRU
Jagiellonian University in Kraków - POLAND
ul. Bobrzyńskiego 12,
30-348 Kraków

PHONE:
+48 12 664 42 00
E-MAIL:
cittru@uj.edu.pl
Fundusze EuropejskieMNiSWInkubator InnowacyjnościUnia Europejska